Testis expressed 50 is essential for maintaining sperm acrosome integrity during epididymal transit
In mammals, sperm formation is completed in the seminiferous tubules within the testis, and sperm maturation occurs during the epididymal transit of the spermatozoa. Sperm morphology drastically changes when abnormal spermatozoa migrate from the testis to the epididymis. Detailed molecular mechanisms for sperm survival in the epididymis have not been determined yet. Globozoospermia is a cause of male infertility and is characterized by round-headed spermatozoa without acrosomes, an abnormal sperm nuclear membrane, and sperm midpiece defects. <i>Testis expressed 50</i> (<i>Tex50</i>) is a testis-enriched gene that is expressed in mice and humans. Using CRISPR-Cas9, we generated <i>Tex50</i> knockout (KO) mice and found that the KO males were sterile due to epididymal sperm malformations and impaired sperm motility. Surprisingly, electron microscopy, sperm morphology, and globozoospermia-related protein expression and localization in the KO testis were all normal. To understand this phenotype in more detail, we created TEX50-mCherry knockin mice to determine the localization of the TEX50 protein during spermatogenesis. The mCherry signals detected a ring-shaped structure surrounding the sperm acrosome and migrated to the posterior region of the sperm head. After the acrosome reaction, most of the spermatozoa retained mCherry signals. These results indicate that the <i>Tex50</i> KO globozoospermia phenotype occurs after the migration of spermatozoa from the testis to the epididymis. We found that sperm membrane protein TEX50 is a putative key molecule to survive against globozoospermia-like malformations in the epididymis. It is essential for complete sperm formation and male fertility in mice.
Authors
- Ferheen Abbasi (ORCID: https://orcid.org/0000-0002-6823-4298)
- Tsutomu Endo (ORCID: https://orcid.org/0000-0001-9394-362X)
- Martin Matthew Matzuk (ORCID: https://orcid.org/0000-0002-1445-8632)
- Katarzyna Kent (ORCID: https://orcid.org/0000-0002-4528-3425)
- Kaori Nozawa (ORCID: https://orcid.org/0000-0002-2256-278X)
- Yoshitaka Fujihara (ORCID: https://orcid.org/0000-0001-8332-3507)
- Haruhiko Miyata (ORCID: https://orcid.org/0000-0003-4758-5803)
- Masahito Ikawa (ORCID: https://orcid.org/0000-0001-9859-6217)
- Naoshi Nagasawa
- Saori Haga
Institutions
- Baylor College of Medicine (US)
- National Cerebral and Cardiovascular Center (JP)
- Institute of Reproductive Medicine (IN)
- Drug Discovery Laboratory (Norway) (NO)
- Osaka International Cancer Institute (JP)
- Medical Technologies (Czechia) (CZ)
- The University of Tokyo (JP)
- University of California, Davis (US)
- The University of Osaka (JP)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1073/pnas.2507930122
- Citations
- 1
- Primary Topic
- Sperm and Testicular Function
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Japan Agency for Medical Research and Development
- National Cerebral and Cardiovascular Center
- Ministry of Education, Culture, Sports, Science and Technology
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Senri Life Science Foundation
- National Institutes of Health
- Chugai Pharmaceutical
- Japan Society for the Promotion of Science
- National Cancer Institute
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Co-creation place formation support program